Welcome to our dedicated page for Art's-Way Manufacturing SEC filings (Ticker: ARTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Art's-Way Manufacturing Co., Inc. filings document operating results, segment performance, governance matters, and shareholder voting for the agricultural equipment and modular buildings manufacturer. Form 8-K reports include results of operations and financial condition for quarterly and fiscal periods, with disclosures tied to Agricultural Products, Modular Buildings, continuing operations, and the completed wind-down of the former Tools segment.
Proxy and annual-meeting filings cover board elections, auditor ratification, advisory executive-compensation votes, equity-award disclosures, and amendments to the 2020 Equity Incentive Plan. The company's filing record also documents shareholder-vote frequency decisions and related governance procedures.
Michael W. Woods, identified as an officer and director of Arts-Way Manufacturing Co., reported two open-market sales of common stock: 4,074 shares sold at $3.769 on 08/06/2025 and 5,525 shares sold at $4.0501 on 08/07/2025. After the first reported sale his beneficial ownership was reported as 32,524 shares, and following the second sale it was 26,999 shares.
The filing also explains the composition of those holdings: portions are fully vested shares and portions are restricted stock subject to staged forfeiture-lapse schedules, with multiple tranches vesting on dates described in the form. No derivative securities were reported on this form.
Arts-Way Manufacturing Co. Inc. (ARTW) filed a Form 144 disclosing an insider’s plan to sell 5,525 common shares through NASDAQ on 08/07/2025. At an aggregate market value of $22,376.80 (~$4.05/sh), the proposed sale equals 17.1 % of the 32,254 shares outstanding stated in the notice.
The stock was acquired via four stock-award grants: 1,022 shares on 01/31/2020 and three blocks of 1,501 shares each in January 2024. The filer—identified as Michael Woods in the recent-sales table—already sold 11,666 shares during the past three months, generating $40,488.23 in gross proceeds (7,592 shares on 07/29/2025 and 4,074 shares on 08/06/2025). Should the new sale proceed, insider dispositions over the period would total 17,191 shares, or 53.3 % of the shares outstanding.
The signing party affirms no undisclosed material adverse information. While the dollar amount is modest, the large percentage of shares involved may increase float and exert supply pressure, meriting close investor attention.
Arts-Way Manufacturing (ARTW) Chief Financial Officer Michael W. Woods reported an open-market sale of 7,592 common shares on 07/29/2025, according to a Form 4 filed 07/31/2025. The shares were sold at an average price of $3.3105, yielding roughly $25,150 in gross proceeds.
After the transaction, Woods’ direct holding stands at 36,597 shares. The position consists of 17,598 fully-vested shares and 18,999 restricted shares scheduled to vest between January 2026 and January 2028, indicating continued long-term exposure.
The disposal represents an estimated 17% reduction from his prior 44,189-share stake. No derivative securities were bought or sold, and no other insiders are listed in the filing.
Art’s-Way Manufacturing (ARTW) reported Q2 FY 2025 results (ended 31 May 2025) that show a sharp swing to profitability driven by a one-time Employee Retention Credit (ERC) refund, while core operations delivered mixed performance.
Income statement highlights
- Quarterly sales fell 5.8 % to $6.34 million; six-month sales down 7.8 % to $11.48 million.
- Gross profit rose 8.0 % to $2.06 million; margin expanded to 32.5 % (28.3 % last year) on better cost control and a richer mix in Modular Buildings.
- Operating income improved to $0.51 million (vs. $0.17 million). Six-month operating income of $0.51 million reversed a $0.21 million loss in FY 2024.
- Other income of $1.46 million reflects ERC refunds (net of $0.41 million consulting fees), lifting pre-tax income to $1.88 million.
- Net income from continuing operations reached $1.48 million (EPS $0.29) versus a small loss last year; six-month net income $1.43 million versus a $0.43 million loss.
Segment performance
- Agricultural Products: Revenue down 11.6 % to $4.03 million; operating loss $0.05 million. Management cites weak row-crop prices and high rates; expects destocking to bottom within 12–18 months.
- Modular Buildings: Revenue up 6.3 % to $2.31 million; operating income surged to $0.56 million with 41.7 % margin as large laboratory projects finished below budget.
Balance sheet & liquidity
- Cash rose to $4,534; line-of-credit balance cut to $1.06 million (from $1.93 million).
- Total liabilities fell 21 % to $7.26 million; equity climbed to $13.62 million.
- Net working capital requirement covenant of $4 million met; next test 30 Nov 2025.
Cash flow
- Operating cash from continuing ops: $1.25 million, boosted by ERC and working-capital releases.
- Investing outflow: $0.21 million for capex; financing outflow: $1.04 million mainly line-of-credit pay-down.
Order backlog
- Combined backlog fell 39 % YoY to $4.73 million (Agricultural $0.86 m; Modular $3.87 m), signaling softer near-term visibility.
Outlook commentary
- Management expects Agricultural demand to improve as dealer inventory normalises and livestock margins remain strong.
- Modular Buildings pipeline remains active; expanded sales leadership aims to tap new research-facility markets.
Key takeaways: The quarter’s profitability is largely attributable to a non-recurring ERC benefit; underlying sales contracted and backlog declined. Nonetheless, lower leverage, higher gross margin and robust Modular Buildings profitability are constructive signs, while Agricultural Products remains pressured.